May 12, 2025

Delayed Puberty: Diabetes Risk Signal?

"Our results are surprising as delayed puberty is generally considered a benign condition."

Conexiant

May 12, 2025

Yearly Blood Tests May Cut Cancer Deaths by 21%

A state-transition model demonstrates that multicancer early detection blood tests significantly reduce late-stage cancer diagnoses and mortality, with annual screening intervals showing superior outcomes compared to biennial testing.

Conexiant

May 09, 2025

Self-Harm Risk Rises Prior to and Following Gabapentinoids 

Researchers tracked over 10,000 patients and found the risk of self-harm was highest before starting gabapentinoids and again shortly after stopping, highlighting key periods for clinical monitoring.

Conexiant

May 09, 2025

Few Patients With STI Receive Recommended Antibiotics: Study

A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.

Conexiant

May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

High Poultry Intake May Be Linked to GI Cancer Mortality

Men who ate over 300 grams of poultry per week had more than double the risk of dying from gastrointestinal cancers, a large Italian study found.

Conexiant

May 08, 2025

Mindfulness Therapy May Reduce Opioid Craving Signals

Mindfulness training helped normalize brain responses to positive emotion in people with opioid use disorder, reducing their craving and improving emotional regulation.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 07, 2025

FDA Approves Low-Dose Chlorthalidone Tablet

The FDA has approved HemiClor, a 12.5-mg chlorthalidone tablet, providing patients with a low-dose option.

Conexiant